Which has higher earnings and valuation, FRMM or CLLS?

Cellectis has higher revenue and earnings than Forum Markets. Cellectis is trading at a lower price-to-earnings ratio than Forum Markets, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Forum Markets $9.41M 7.81 -$450.52M -$36.07 N/A Cellectis $68.07M 4.39 -$67.59M -$0.67 N/A

Is FRMM or CLLS more profitable?

Forum Markets has a net margin of 0.00% compared to Cellectis' net margin of -89.51%. Cellectis' return on equity of -80.66% beat Forum Markets' return on equity. Company Net Margins Return on Equity Return on Assets Forum Markets N/A -242.09% -135.46% Cellectis -89.51% -80.66% -20.51%

Do analysts rate SIGA or FRMM?

Forum Markets has a consensus price target of $10.00, indicating a potential upside of 98.02%. Given Forum Markets' stronger consensus rating and higher possible upside, analysts clearly believe Forum Markets is more favorable than Siga Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Siga Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Forum Markets 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Is FRMM or TENX more profitable?

Tenax Therapeutics' return on equity of -56.32% beat Forum Markets' return on equity. Company Net Margins Return on Equity Return on Assets Forum Markets N/A -242.09% -135.46% Tenax Therapeutics N/A -56.32% -53.12%

Is DMAC or FRMM more profitable?

DiaMedica Therapeutics' return on equity of -77.15% beat Forum Markets' return on equity. Company Net Margins Return on Equity Return on Assets DiaMedica Therapeutics N/A -77.15% -69.23% Forum Markets N/A -242.09% -135.46%

Is ORGO or FRMM more profitable?

Forum Markets has a net margin of 0.00% compared to Organogenesis' net margin of -0.84%. Organogenesis' return on equity of 9.63% beat Forum Markets' return on equity. Company Net Margins Return on Equity Return on Assets Organogenesis -0.84% 9.63% 4.76% Forum Markets N/A -242.09% -135.46%

Forum Markets (FRMM) Competitors

$5.05 0.00 (0.00%)

Closing price 06/18/2026 04:00 PM Eastern

Extended Trading

$5.11 +0.06 (+1.19%)

As of 06/18/2026 07:58 PM Eastern

Compare

FRMM vs. CLLS, SIGA, TENX, DMAC, and ORGO

Should you buy Forum Markets stock or one of its competitors? MarketBeat compares Forum Markets with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Forum Markets include Cellectis (CLLS), Siga Technologies (SIGA), Tenax Therapeutics (TENX), DiaMedica Therapeutics (DMAC), and Organogenesis (ORGO). These companies are all part of the "pharmaceutical products" industry.

How does Forum Markets compare to Cellectis?

Forum Markets (NASDAQ:FRMM) and Cellectis (NASDAQ:CLLS) are both small-cap pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Forum Markets has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market. Comparatively, Cellectis has a beta of 2.86, meaning that its stock price is 186% more volatile than the broader market.

4.1% of Forum Markets shares are held by institutional investors. Comparatively, 63.9% of Cellectis shares are held by institutional investors. 15.1% of Forum Markets shares are held by company insiders. Comparatively, 16.4% of Cellectis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Forum Markets currently has a consensus price target of $10.00, indicating a potential upside of 98.02%. Cellectis has a consensus price target of $7.00, indicating a potential upside of 134.90%. Given Cellectis' stronger consensus rating and higher possible upside, analysts clearly believe Cellectis is more favorable than Forum Markets.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Forum Markets	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Cellectis	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83

In the previous week, Cellectis had 1 more articles in the media than Forum Markets. MarketBeat recorded 1 mentions for Cellectis and 0 mentions for Forum Markets. Forum Markets' average media sentiment score of 0.00 equaled Cellectis'average media sentiment score.

Company	Overall Sentiment
Forum Markets	Neutral
Cellectis	Neutral

Forum Markets has a net margin of 0.00% compared to Cellectis' net margin of -89.51%. Cellectis' return on equity of -80.66% beat Forum Markets' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Forum Markets	N/A	-242.09%	-135.46%
Cellectis	-89.51%	-80.66%	-20.51%

Cellectis has higher revenue and earnings than Forum Markets. Cellectis is trading at a lower price-to-earnings ratio than Forum Markets, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Forum Markets	$9.41M	7.81	-$450.52M	-$36.07	N/A
Cellectis	$68.07M	4.39	-$67.59M	-$0.67	N/A

Summary

Cellectis beats Forum Markets on 12 of the 15 factors compared between the two stocks.

How does Forum Markets compare to Siga Technologies?

Siga Technologies (NASDAQ:SIGA) and Forum Markets (NASDAQ:FRMM) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

Forum Markets has a consensus price target of $10.00, indicating a potential upside of 98.02%. Given Forum Markets' stronger consensus rating and higher possible upside, analysts clearly believe Forum Markets is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Siga Technologies	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Forum Markets	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

55.4% of Siga Technologies shares are owned by institutional investors. Comparatively, 4.1% of Forum Markets shares are owned by institutional investors. 2.7% of Siga Technologies shares are owned by company insiders. Comparatively, 15.1% of Forum Markets shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Siga Technologies has a beta of 0.91, indicating that its share price is 9% less volatile than the broader market. Comparatively, Forum Markets has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market.

Siga Technologies has a net margin of 21.58% compared to Forum Markets' net margin of 0.00%. Siga Technologies' return on equity of 10.60% beat Forum Markets' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Siga Technologies	21.58%	10.60%	8.94%
Forum Markets	N/A	-242.09%	-135.46%

Siga Technologies has higher revenue and earnings than Forum Markets. Forum Markets is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Siga Technologies	$93.78M	3.30	$23.28M	$0.27	16.00
Forum Markets	$9.41M	7.81	-$450.52M	-$36.07	N/A

In the previous week, Siga Technologies' average media sentiment score of 0.00 equaled Forum Markets'average media sentiment score.

Company	Overall Sentiment
Siga Technologies	Neutral
Forum Markets	Neutral

Summary

Siga Technologies beats Forum Markets on 8 of the 15 factors compared between the two stocks.

How does Forum Markets compare to Tenax Therapeutics?

Forum Markets (NASDAQ:FRMM) and Tenax Therapeutics (NASDAQ:TENX) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

Forum Markets has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market. Comparatively, Tenax Therapeutics has a beta of 0.98, meaning that its share price is 2% less volatile than the broader market.

Tenax Therapeutics has lower revenue, but higher earnings than Forum Markets. Tenax Therapeutics is trading at a lower price-to-earnings ratio than Forum Markets, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Forum Markets	$9.41M	7.81	-$450.52M	-$36.07	N/A
Tenax Therapeutics	N/A	N/A	-$52.60M	-$1.40	N/A

4.1% of Forum Markets shares are held by institutional investors. Comparatively, 1.7% of Tenax Therapeutics shares are held by institutional investors. 15.1% of Forum Markets shares are held by company insiders. Comparatively, 3.1% of Tenax Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Tenax Therapeutics' average media sentiment score of 1.00 beat Forum Markets' score of 0.00 indicating that Tenax Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
Forum Markets	Neutral
Tenax Therapeutics	Positive

Forum Markets currently has a consensus price target of $10.00, indicating a potential upside of 98.02%. Tenax Therapeutics has a consensus price target of $39.67, indicating a potential upside of 230.56%. Given Tenax Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Tenax Therapeutics is more favorable than Forum Markets.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Forum Markets	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Tenax Therapeutics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83

Tenax Therapeutics' return on equity of -56.32% beat Forum Markets' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Forum Markets	N/A	-242.09%	-135.46%
Tenax Therapeutics	N/A	-56.32%	-53.12%

Summary

Tenax Therapeutics beats Forum Markets on 8 of the 13 factors compared between the two stocks.

How does Forum Markets compare to DiaMedica Therapeutics?

DiaMedica Therapeutics (NASDAQ:DMAC) and Forum Markets (NASDAQ:FRMM) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

10.1% of DiaMedica Therapeutics shares are owned by institutional investors. Comparatively, 4.1% of Forum Markets shares are owned by institutional investors. 5.0% of DiaMedica Therapeutics shares are owned by company insiders. Comparatively, 15.1% of Forum Markets shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

DiaMedica Therapeutics has a beta of 0.97, meaning that its stock price is 3% less volatile than the broader market. Comparatively, Forum Markets has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market.

DiaMedica Therapeutics presently has a consensus target price of $12.33, indicating a potential upside of 110.83%. Forum Markets has a consensus target price of $10.00, indicating a potential upside of 98.02%. Given DiaMedica Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe DiaMedica Therapeutics is more favorable than Forum Markets.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DiaMedica Therapeutics	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
Forum Markets	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, DiaMedica Therapeutics had 1 more articles in the media than Forum Markets. MarketBeat recorded 1 mentions for DiaMedica Therapeutics and 0 mentions for Forum Markets. DiaMedica Therapeutics' average media sentiment score of 0.40 beat Forum Markets' score of 0.00 indicating that DiaMedica Therapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
DiaMedica Therapeutics	Neutral
Forum Markets	Neutral

DiaMedica Therapeutics has higher earnings, but lower revenue than Forum Markets. DiaMedica Therapeutics is trading at a lower price-to-earnings ratio than Forum Markets, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DiaMedica Therapeutics	N/A	N/A	-$32.77M	-$0.71	N/A
Forum Markets	$9.41M	7.81	-$450.52M	-$36.07	N/A

DiaMedica Therapeutics' return on equity of -77.15% beat Forum Markets' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DiaMedica Therapeutics	N/A	-77.15%	-69.23%
Forum Markets	N/A	-242.09%	-135.46%

Summary

DiaMedica Therapeutics beats Forum Markets on 10 of the 15 factors compared between the two stocks.

How does Forum Markets compare to Organogenesis?

Organogenesis (NASDAQ:ORGO) and Forum Markets (NASDAQ:FRMM) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

49.6% of Organogenesis shares are held by institutional investors. Comparatively, 4.1% of Forum Markets shares are held by institutional investors. 18.8% of Organogenesis shares are held by insiders. Comparatively, 15.1% of Forum Markets shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Organogenesis had 3 more articles in the media than Forum Markets. MarketBeat recorded 3 mentions for Organogenesis and 0 mentions for Forum Markets. Organogenesis' average media sentiment score of 0.16 beat Forum Markets' score of 0.00 indicating that Organogenesis is being referred to more favorably in the media.

Company	Overall Sentiment
Organogenesis	Neutral
Forum Markets	Neutral

Organogenesis presently has a consensus target price of $5.75, indicating a potential upside of 135.66%. Forum Markets has a consensus target price of $10.00, indicating a potential upside of 98.02%. Given Organogenesis' higher probable upside, analysts clearly believe Organogenesis is more favorable than Forum Markets.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organogenesis	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Forum Markets	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Organogenesis has higher revenue and earnings than Forum Markets. Organogenesis is trading at a lower price-to-earnings ratio than Forum Markets, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organogenesis	$512.59M	0.61	$37.03M	-$0.19	N/A
Forum Markets	$9.41M	7.81	-$450.52M	-$36.07	N/A

Organogenesis has a beta of 1.32, suggesting that its share price is 32% more volatile than the broader market. Comparatively, Forum Markets has a beta of 1.45, suggesting that its share price is 45% more volatile than the broader market.

Forum Markets has a net margin of 0.00% compared to Organogenesis' net margin of -0.84%. Organogenesis' return on equity of 9.63% beat Forum Markets' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organogenesis	-0.84%	9.63%	4.76%
Forum Markets	N/A	-242.09%	-135.46%

Summary

Organogenesis beats Forum Markets on 10 of the 16 factors compared between the two stocks.

Get Forum Markets News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FRMM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FRMM vs. The Competition

Export

Metric	Forum Markets	Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$73.44M	$2.97B	$4.41B	$12.59B
Dividend Yield	N/A	15.19%	10.42%	5.74%
P/E Ratio	-0.14	13.65	22.12	24.44
Price / Sales	7.81	3,161.48	213.46	90.36
Price / Cash	N/A	26.72	41.09	55.09
Price / Book	0.40	4.91	19.93	6.58
Net Income	-$450.52M	-$39.47M	$115.37M	$337.17M
7 Day Performance	-5.61%	0.44%	0.70%	0.83%
1 Month Performance	21.69%	0.83%	1.18%	3.27%
1 Year Performance	N/A	17.40%	14.83%	36.05%

Forum Markets Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FRMM Forum Markets	2.0881 of 5 stars	$5.05 flat	$10.00 +98.0%	N/A	$73.44M	$6.55M	N/A	7
CLLS Cellectis	1.9457 of 5 stars	$3.09 flat	$7.00 +126.5%	+115.9%	$310.05M	$79.59M	N/A	290	Gap Up
SIGA Siga Technologies	0.4235 of 5 stars	$4.32 +0.2%	N/A	-32.7%	$309.85M	$94.57M	16.00	40	Positive News
TENX Tenax Therapeutics	2.8271 of 5 stars	$11.48 +7.0%	$39.67 +245.5%	+111.6%	$304.51M	N/A	N/A	9	Positive News Gap Up High Trading Volume
DMAC DiaMedica Therapeutics	1.4232 of 5 stars	$5.65 +3.5%	$12.33 +118.3%	+53.1%	$304.44M	N/A	N/A	20

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FRMM) was last updated on 6/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Forum Markets (FRMM) Competitors

FRMM vs. CLLS, SIGA, TENX, DMAC, and ORGO

How does Forum Markets compare to Cellectis?

Summary

How does Forum Markets compare to Siga Technologies?

Summary

How does Forum Markets compare to Tenax Therapeutics?

Summary

How does Forum Markets compare to DiaMedica Therapeutics?

Summary

How does Forum Markets compare to Organogenesis?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FRMM vs. The Competition

Forum Markets Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Forum Markets (FRMM) Competitors

FRMM vs. CLLS, SIGA, TENX, DMAC, and ORGO

How does Forum Markets compare to Cellectis?

Which has more risk & volatility, FRMM or CLLS?

Do institutionals & insiders believe in FRMM or CLLS?

Do analysts prefer FRMM or CLLS?

Does the media refer more to FRMM or CLLS?

Is FRMM or CLLS more profitable?

Which has higher earnings and valuation, FRMM or CLLS?

Summary

How does Forum Markets compare to Siga Technologies?

Do analysts rate SIGA or FRMM?

Do insiders and institutionals have more ownership in SIGA or FRMM?

Which has more risk and volatility, SIGA or FRMM?

Is SIGA or FRMM more profitable?

Which has preferable valuation and earnings, SIGA or FRMM?

Does the media favor SIGA or FRMM?

Summary

How does Forum Markets compare to Tenax Therapeutics?

Which has more volatility and risk, FRMM or TENX?

Which has stronger earnings and valuation, FRMM or TENX?

Do institutionals & insiders believe in FRMM or TENX?

Does the media refer more to FRMM or TENX?

Do analysts rate FRMM or TENX?

Is FRMM or TENX more profitable?

Summary

How does Forum Markets compare to DiaMedica Therapeutics?

Do insiders & institutionals hold more shares of DMAC or FRMM?

Which has more risk and volatility, DMAC or FRMM?

Do analysts rate DMAC or FRMM?

Does the media prefer DMAC or FRMM?

Which has higher valuation and earnings, DMAC or FRMM?

Is DMAC or FRMM more profitable?

Summary

How does Forum Markets compare to Organogenesis?

Do insiders and institutionals have more ownership in ORGO or FRMM?

Does the media favor ORGO or FRMM?

Do analysts rate ORGO or FRMM?

Which has higher earnings and valuation, ORGO or FRMM?

Which has more volatility & risk, ORGO or FRMM?

Is ORGO or FRMM more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FRMM vs. The Competition

Forum Markets Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools